These results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 aid the idea of targeting ACKR3 as a unique strategy to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Problems. We independently investigate, review, and https://leee402woh5.ziblogs.com/profile